Get involved. Stay informed.

If you share our passion for improving patients’ lives through medical innovation and want to get involved in our audacious vision to shape the future of human health, we invite you to connect with us!

Sign up to be notified of all our educational events, join an upcoming one listed below, subscribe to our newsletter, read our blog, follow us on social media, or just reach out via email.

Welcome to the Fogarty Innovation community!

Upcoming Events

The Early Clinical Studies Playbook:
Leveraging Eastern European Data for US Regulations

Lunch & Learn

Tuesday, October 27, 12:00 – 1:30 pm

The need for First-In-Human and Early Feasibility Studies can be a daunting consideration for early stage medtech startups. Resources, cost, time and regulatory hurdles all come into the calculus about how, when and where to run these studies. Learn from the experience of a well-respected CRO which specializes in conducting these studies for US-based companies in several Eastern European countries.

Email Fogarty Education to register.

Medtech Innovation Forum

TCT® 2026

Saturday, October 31, 8:00 am – 5:45 pm

Organized by Fogarty Innovation and the Cardiovascular Research Foundation (CRF) the Medtech Innovation Forum brings together visionary leaders from across the medtech landscape to confront the most urgent challenges in healthcare today, offering bold solutions, pioneering insights, and forward-looking strategies to shape the future of patient care. Attendees will also witness the highly anticipated TCT® Shark Tank, showcasing technologies with the potential to revolutionize care across clinical areas, as finalists compete for a prestigious $200,000 award from the Jon DeHaan Foundation. This full-day event launches TCT, the annual scientific symposium of CRF.

Click here to register

Scientific Sessions

American Heart Association

November 6 – 9, 2026

Join us in Chicago for Scientific Sessions! This year, Fogarty is collaborating with the American Heart Association to produce the Innovation Forum on November 6, a one-day, high-energy experience designed to help clinicians, scientists, and innovators turn novel ideas into real-world solutions. Through candid conversations with founders, investors, and industry leaders, participants will explore the path from discovery to startup across cardiovascular and brain health.

Click here to learn more

In the News

The Lancet: Thomas Fogarty Obituary

Thomas J. Fogarty, MD, is the founder of Fogarty Innovation.

Nominations Open for the Second Annual Thomas J. Fogarty Prize Honoring High-Impact Medtech Innovations

2026 TJF nominations open April 2.

Disrupting Childbirth Care: Why Birth Is Riskier Than Being a Fighter Pilot

Materna Medical is a Fogarty Company in Residence.

Spring Forward: In Pursuit of a Medical Device for Children with Short Gut Syndrome

Eclipse Regenesis is a Fogarty Company in Residence.

Tom Fogarty: In His Own Words

Thomas J. Fogarty, MD, is the founder of Fogarty Innovation.

The Thomas J. Fogarty Innovation Prize and the FARAPULSE Team: Transformative Innovation Brought to Life

Winners of the 2025 TJF Prize.

Blog

Fogarty Lunch & Learn Explores FDA Breakthrough and TAP Programs

Fogarty Innovation’s Lunch & Learn sessions provide a unique opportunity for knowledge sharing amongentrepreneurs and members of the industry as a key part of the organization’s mission to empower innovators in their quest to transform healthcare and...

Ferolyn Fellowship Class of 2024 Spotlight: Saniya Ali

Saniya Ali is the co-founder and chief technology officer of Watershed Therapeutics, a Seattle-based, early-stage company dedicated to transforming bladder health through a novel platform that delivers drugs locally to prevent chronic UTIs in post-menopausal women and...

Kurt Smith Brings an Impressive Legacy to his Role as Fogarty Advisor

From music to engineering, Kurt Smith, D.Sc., a pioneer in the medtech industry who recently joined the Fogarty team as an advisor, made a remarkable professional pivot that was incredibly fortunate for patients and the medtech industry as a whole. ...